Atara Biotherapeutics Inc — Quarterly Cash Flow (NASDAQ:ATRA) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 142.71 M109.1 M62.04 M36.9 M30.17 M Total liabilities 233.25 M206.38 M117.11 M71.94 M66.8 M Total equity 90.54 M97.28 M55.07 M35.04 M36.63 M Total liabilities & shareholders' equities 142.71 M109.1 M62.04 M36.9 M30.17 M Total debt ————— Net debt —————

Новости

Atara продлевает срок выплаты $9 млн до 2028 года

Atara extends $9M milestone payment deadline to 2028

Директор Atara Bio Джеймс Хуанг продает акции на $489 тыс.

Atara Bio director Huang James sells $489k in shares

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

Рынок акций США закрылся ростом, Dow Jones прибавил 0,17%

FDA отклонило заявку Atara на tabelecleucel в неожиданном повороте

FDA rejects Atara’s tabelecleucel application in surprise reversal

Акции Atara Biotherapeutics рухнули после отказа FDA

Atara Biotherapeutics stock plunges after FDA rejects cancer therapy

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)

Why Is Atara Biotherapeutics Stock Sinking Monday? - Atara Biotherapeutics (NASDAQ:ATRA)